Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains

Jack van Horssen, Rob A I de Vos, Ernst N H Jansen Steur, Guido David, Pieter Wesseling, Robert M W de Waal, Marcel M Verbeek

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

alpha-Synuclein is the major constituent of Lewy bodies and Lewy neurites in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Relatively little is known about the exact mechanism of alpha-synuclein deposition and fibrillization in these alpha-synucleinopathies. In order to better understand the pathogenesis of alpha-synucleinopathies it is important to identify molecules that regulate the fibrillization of alpha-synuclein. Since it has been demonstrated that heparan sulfate proteoglycans (HSPGs) and glycosaminoglycans (GAGs) promote the conversion of non-fibrillar amyloid beta-protein (Abeta) into neurotoxic fibrillar Abeta in Alzheimer's disease, they might also be involved in alpha-synuclein aggregation. It was the aim of our study to examine the distribution pattern of these macromolecules in PD brains and the possible association with Lewy bodies and Lewy neurites. Although HSPGs clearly colocalized with senile plaques, we were unable to identify HSPGs or GAGs in Lewy bodies and Lewy neurites and therefore concluded that it is likely that alpha-synuclein fibrillization and stabilization occurs independently of the presence of HSPGs or GAGs.

Original languageEnglish
Pages (from-to)469-74
Number of pages6
JournalJournal of Alzheimer's Disease
Volume6
Issue number5
Publication statusPublished - Oct 2004

Cite this

van Horssen, J., de Vos, R. A. I., Steur, E. N. H. J., David, G., Wesseling, P., de Waal, R. M. W., & Verbeek, M. M. (2004). Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains. Journal of Alzheimer's Disease, 6(5), 469-74.